Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
4-7-2021 10:00 AM

Inwardly Rectifying Potassium Channels: Regulators of Myogenic
Tone in Cerebrovascular Smooth Muscle
Jacob Fletcher, The University of Western Ontario
Supervisor: Welsh, Donald G., The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Science degree in
Physiology and Pharmacology
© Jacob Fletcher 2021

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Cellular and Molecular Physiology Commons

Recommended Citation
Fletcher, Jacob, "Inwardly Rectifying Potassium Channels: Regulators of Myogenic Tone in
Cerebrovascular Smooth Muscle" (2021). Electronic Thesis and Dissertation Repository. 7708.
https://ir.lib.uwo.ca/etd/7708

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract
In cerebral arteries, inwardly rectifying potassium channels (KIR) contribute to smooth
muscle hyperpolarization to control arterial diameter and tone. Emerging evidence
highlighted their regulation by pressure, though the underlying mechanism remains
unclear. This thesis explored this concept through examination of KIR channels in mouse
and rat cerebral vascular smooth muscle (VSM). Experiments progressed from isolated
cells to whole animals, employing electrophysiology, immunocytochemistry, proximity
ligation assay, and arterial spin-labelling MRI techniques. Initial experiments indicated that
KIR activity persists beyond KIR2.1 knockout in smooth muscle, clarifying their molecular
composition. Our subsequent study identified key structural components involved in
KIR mechanosensing. Disruption of the cytoskeleton impaired the KIR pressure response in
isolated cells. Syntrophin and caveolin-1, protein intermediates known to facilitate actinchannel interactions, were both identified in VSM cells and found co-localized with KIR2.2.
In summary, this thesis provides insight into the composition, function, and associated
mechanotransduction complex of KIR channels in VSM.

Keywords
Myogenic tone, KIR2.1, KIR2.2, ion channels, mechanosensitivity, actin, syntrophin,
caveolae, cytoskeleton, cerebral arteries, blood flow control.
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Summary
Blood is supplied to the brain through a network of resistance arteries that continually
adjust their diameter to maintain constant flow. They achieve this through a layer of smooth
muscle which contracts and relaxes to constrict or dilate the vessel. Ion channels control
the contractile state (tone) of vascular smooth muscle by changing their activity in response
to external forces such as pressure. Inwardly rectifying potassium channels (KIR) are among
these channels and have recently been found to respond to pressure, although it is unclear
how this occurs. This project improved our understanding of how vessels sense pressure by
studying KIR channels in the smooth muscle of cerebral arteries. Our first study utilized a
genetic knockout mouse model to investigate both the role and molecular composition of
vascular KIR channels. Through these experiments, we determined which specific subtypes
of KIR channels were functionally relevant in smooth muscle cells. Our second study sought
to uncover the mechanism that KIR channels utilize to sense changes in pressure. We found
that KIR pressure sensitivity was dependent on interactions with several structural proteins
within the cell. By identifying these components, our work provides new targets to
investigate in disease states where arterial tone is disrupted such as hypertension and
metabolic syndrome. To summarize, the conclusions drawn from this study improve our
knowledge of the mechanisms arteries use to translate physical stimuli into diameter
changes.
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Chapter 1:
Introduction
1.1 The Myogenic Response
Within the mammalian circulatory system, a network of resistance arteries is responsible
for coordinating blood flow throughout the tissue (Segal & Duling, 1986). Resistance
arteries accomplish this through their ability to change diameter in response to a variety of
electrical, neuronal and physical stimuli including transmural flow and pressure (Bevan &
Laher, 1991; Zhang et al., 2002; Diep et al., 2005). The cerebral vascular network is
particularly reactive to mechanical forces; as blood pressure increases, vessels constrict and
reduce their diameter through an autoregulatory process known as the myogenic response.
This phenomenon is essential to brain function as it allows for constant perfusion over a
range of intraluminal pressures, protection of downstream capillaries, and fine-tuning of
regional flow (Davis & Hill, 1999; Cole & Welsh, 2011). A layer of vascular smooth
muscle (VSM) lining the arterial wall is responsible for both sensing and responding to
changes in pressure, and its underlying mechanisms have been studied thoroughly (Figure
1.1). Increasing pressure modulates ion channel activity to depolarize VSM, which in turn
opens voltage-gated calcium channels (VGCCs) allowing for Ca2+ entry into the cell
(Thorneloe & Nelson, 2005). As [Ca2+] rises, its binds calmodulin to form a complex that
activates myosin light chain kinase (MLCK). MLCK then phosphorylates serine-19 of
myosin regulatory light chain 20 (MLC20) to enable its interaction with actin, activation of
myosin ATPase, and subsequent cross-bridge cycling needed for muscle contraction (Cole
& Welsh, 2011). In opposition of MLCK action, myosin light chain phosphatase (MLCP)
dephosphorylates MLC20 to drive vessel relaxation (Hartshorne et al., 1998). It is through
this balance of MLCK and MLCP activity that the overall contractile state or “tone” of the
vessel is determined. The development of adequate myogenic tone is essential for normal
cardiovascular function; VSM dysfunction has been observed in the pathogenesis of several
disease states including stroke, hypertension, and dementia (Izzard et al., 2003; Toth et al.,
2013, 2017).
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Figure 1.1: Mechanism of myogenic tone development in vascular smooth muscle.
Rising intraluminal pressure is detected by mechanosensitive ion channels which
depolarize the membrane. VGCCs then open to allow for Ca2+ entry which interacts with
calmodulin to activate MLCK. Upon MLC20 phosphorylation of serine-19 by MLCK,
myosin binds actin and cross-bridge cycling occurs to contract VSM and decrease arterial
diameter (Modified from Cole & Welsh, 2011).
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In addition to VSM, the control of myogenic tone is also influenced by the vascular
endothelium. Endothelial cells form the internal layer of vessels —known as the intima—
and are recognized as dynamic regulators of smooth muscle contractility and tone (Sandoo
et al., 2010). Endothelial cells modulate tone through two distinct processes: by releasing
vasoactive factors or by propagating electrical signals along the vessel wall and into the
adjacent smooth muscle layer. The vascular endothelium has long been understood to
release vasodilatory or vasoconstrictive factors in response to hormonal, neuronal, and
hemodynamic stimuli like shear stress. Among such factors are nitric oxide (NO),
endothelium-derived hyperpolarizing factor, prostacyclin, endothelin-1, and thromboxane
A2 (Nilius & Droogmans, 2001; Sandoo et al., 2010). These factors are synthesized within
the endothelium and diffuse out of cells to act on neighbouring VSM, effectively altering
its contractile state to cause vasoconstriction or dilation. The second mechanism that
endothelial cells employ to alter myogenic tone arises from their ability to propagate
electrical signals along the vessel wall. Briefly, gap junctions couple endothelial cells with
one another and with VSM cells to permit the sharing of electrical charge (Welsh & Segal,
1998). This process is thought to enable the coordination of blood flow responses across
multiple arterial segments in response to stimuli that alter VM of either cell layer. For
example, endothelial cells sense shear stress via inwardly rectifying K+ (KIR) channels and
elicit vasodilatory responses in VSM (Sancho et al., 2019). As well, electrical coupling
between endothelial cells and VSM explains how capillaries communicate with upstream
arterioles to fine-tune local blood delivery (Song & Tyml, 1993). The discovery of this socalled intercellular conduction has prompted significant research in resistance arteries of
highly perfused organs, such as the brain, where coordination is critical to healthy function.
The breakdown of endothelial conduction has been reported to dysregulate cerebral
vasomotor responses of healthy mice and further impair recovery following
cerebrovascular stroke injury (Zechariah et al., 2020). These findings highlight that
myogenic tone control is a complex and heterogenous process in resistance arteries,
requiring contributions from both VSM and endothelial cell types to form a dynamically
responsive system.
While the downstream contractile pathways of the myogenic response have been welldefined in VSM, the exact mechanism that allows a vessel to transduce increased pressure
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into membrane depolarization remains unclear. It has been long understood that arterial
membrane potential (VM) is determined by the activity of ion channels present in the
smooth muscle layer (Thorneloe & Nelson, 2005). As a result, channels that exhibit
mechanosensitivity are often investigated for their ability to act as “pressure sensors” to
depolarize VM and initiate the myogenic response (Davis et al., 1992; Welsh et al., 2002).

1.2 Ion Channels in Vascular Smooth Muscle
Arterial myocytes are unique from other muscle type cells in that the majority of their
contractile Ca2+ is externally-sourced through VGCCs (Thorneloe & Nelson, 2005).
Consequently, smooth muscle contractility is tightly coupled to VM, which in turn is set by
multiple ion channels working simultaneously to maintain a balance between depolarizing
and hyperpolarizing currents. Depolarizing conductances are provided through a
combination of VGCCs, chloride channels (Cl-), and non-selective cation channels (Nelson
et al., 1997; Albert & Large, 2002; Thorneloe & Nelson, 2005). Potassium (K+) channels
oppose membrane depolarization by passing outward hyperpolarizing currents, thus
preventing Ca2+ entry and promoting smooth muscle relaxation and vasodilation. Several
families of K+ channels have been identified in VSM to date: inwardly rectifying (KIR),
voltage-gated (KV), small/intermediate/large conductance calcium-activated (SKCa, IKCa,
BKCa), and ATP-sensitive (KATP) (Nelson & Quayle, 1995). These channels act collectively
to set VM, of which the operational range is known to lie between -55 and -35 mV under
physiological conditions (Knot & Nelson, 1998; Cole & Welsh, 2011).
Beyond setting VM, vascular ion channels also serve as regulatory targets by which external
stimuli modulate vessel contractility. Several ion channels present in VSM are known to
alter their activity in response to physical forces exerted on the vessel wall (Davis et al.,
1992; Welsh et al., 2000). The activation of these channels is thought to initiate the
myogenic response by depolarizing VSM to drive Ca2+ entry. Current evidence suggests
the involvement of non-selective transient receptor potential cation (TRPC) and stretchactivated Cl- channels; both are known to produce inward depolarizing currents upon
mechanical stimulation. Blockade of either channel prevents VSM depolarization of intact
vessels but only at high transluminal pressures, implying their stretch-activation (Nelson et
al., 1997; Earley et al., 2004; Thorneloe & Nelson, 2005). KIR channels are among the
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newest known participants of vascular mechanosensing, with recent studies demonstrating
their suppression by pressure (Wu et al., 2007; Sancho et al., 2019). In the context of the
cerebral circulation, KIR channels are especially relevant as they are active in setting VM
and well-expressed in resistance-sized cerebral arteries (Quayle et al., 1993; Sancho et al.,
2019). To date, our understanding of KIR mechanosensitivity is limited and more work is
needed to determine its significance within the myogenic response.

1.3 KIR Structure & Biophysical Properties
Initially discovered in skeletal muscle, KIR channels have been identified in numerous cell
types including cardiac myocytes, glial cells, neurons, endothelial and smooth muscle cells
(Katz, 1949; Gahwiler & Brown, 1985; Kurachi, 1985; Fang et al., 2005; Sancho et al.,
2019). The common molecular structure of KIR channels is described as a tetrameric
assembly of α-subunits. Each individual subunit consists of two membrane-spanning
domains: an outer TM1 helix and an inner TM2 helix that lines the central pore. The pore
itself consists of three regions: a selectivity filter, a water-filled cavity, and a narrow
cytoplasmic-facing region made up of four TM2 helix bases. Subunits are connected by a
highly conserved extracellular pore forming region that provides K+ selectivity (H5), along
with intracellular cytoplasmic amino (N) and carboxyl (C) termini (Raab-Graham &
Vandenberg, 1998; Kuo, 2003; Hibino et al., 2010). KIR channels are named for their ability
to pass inward currents more easily at membrane potentials negative to the potassium
equilibrium potential (EK). This property arises from interactions between the channel pore
with Mg2+ and intracellular polyamines (spermine and spermidine) that prevent outward
currents upon membrane depolarization (Lopatin et al., 1994; Kurata et al., 2006). At
hyperpolarized membrane potentials, Mg2+ and polyamines dissociate from the pore
allowing for inward flux of K+. Negatively charged residues within the TM2 helix (D172
and D173 in KIR2.1 and KIR2.2, respectively) have been identified as key binding sites for
these interactions in KIR2.x channels and are considered critical for inward rectification
(Lopatin et al., 1994). Within the cytoplasmic region, KIR subunits also possess a consensus
motif (amino acids Ser-Glu-Ile) at their carboxyl terminus that is recognized by PDZ
domain containing proteins. These motifs facilitate interactions between KIR channels and
endogenous proteins, and are thought to play key roles in the organization of cellular
signalling complexes (Leonoudakis et al., 2004; Lee & Zheng, 2010). These distinct
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structural and biophysical properties enable a diverse range of functions for KIR channels
in the cerebral vasculature.

1.4 KIR Channel Function in Arterial Smooth Muscle
In cerebral arteries, KIR channels are expressed in both smooth muscle and endothelial cell
types and are largely comprised of subunits from the strong-rectifying KIR2.x subfamily
(Quayle et al., 1993; Sancho et al., 2019). The smooth muscle channel pool consists of KIR
2.1, KIR2.2, and KIR2.4 subunits, however, only KIR2.1 is considered essential for the
formation of functional channels (Bradley et al., 1999). Interestingly, the distribution of
smooth muscle KIR channels is known to vary between different vascular networks. KIR2.x
activity has been observed in both cerebral and coronary myocytes but not those from
mesenteric vessels, suggesting that distinct phenotypes exist between vessels (Smith et al.,
2008). Strong-rectifying KIR2.x channels possess an electrophysiological profile defined
by several characteristics: robust inward rectification, a small outward component,
potentiation by extracellular K+, and sensitivity to micromolar Ba2+ (Schram et al., 2003;
Smith et al., 2008). As previously described, KIR channels produce robust inward currents
when VM is negative to EK (~-85mV under physiological conditions) (Thorneloe & Nelson,
2005). However, resting arterial VM is positive to EK; therefore, a small outward component
is observed as the membrane depolarizes prior to polyamine and Mg2+ blockade (Knot et
al., 1996; Smith et al., 2008). As a result of this property, vascular KIR channels pass current
that hyperpolarizes VSM and prevents VGCC opening. The outward current of KIR
channels also increases in magnitude as the cell hyperpolarizes, a process known as
negative slope conductance (Dhamoon et al., 2004). This permits KIR potentiation by
extracellular K+: as [K+] rises, EK shifts rightward and peak outward currents are enhanced.
Through this property, KIR channels have been reported to amplify the hyperpolarizing
effects of other K+ channels expressed in VSM (Smith et al., 2008). Consequently, KIR
channels are often investigated as effectors of functional hyperemia in metabolically active
tissues where K+ secretion is high, such as skeletal muscle (Crecelius et al., 2014). Finally,
the sensitivity of KIR2.x channels to micromolar concentrations of Ba2+ has been widely
used to characterize the current in electrophysiological studies. Channels composed of
KIR2.1 and KIR2.2 subunits are highly sensitive to BaCl2, with IC50 ranging from 5 to 16
μM at -120 mV depending on subunit configuration (Dhamoon et al., 2004).
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Arterial KIR channels were initially studied as a passive conductance; however, a growing
body of research has highlighted their ability to act as sensors of intraluminal pressure.
When swelled in hyposmotic solution, whole-cell KIR currents from cerebral VSMCs are
readily suppressed (Wu et al., 2007; Sancho et al., 2019). Hyposmotic challenge typically
activates mechanosensitive channels, making the case of KIR suppression unique (Gomis et
al., 2008; Brohawn, 2015). This effect has also been observed in vessel myography
preparations where Ba2+-induced constriction, a common marker for KIR function, was
found to be inversely proportional to intravascular pressure (Sancho et al., 2019). Further
identification of downstream signalling processes is needed to determine how pressure
impacts KIR open probability. Current models of ion channel mechanosensitivity offer
insight into the mechanisms used by cells to transduce physical forces into ionic
conductances, and often recognize the importance of cell structural components.

1.5 Cellular Mechanisms of Mechanosensitivity
The ability for cells to sense and respond to physical changes in their surrounding
environment is essential for physiological function. Mechanosensation is the process by
which physical forces exerted on a cell are transduced into chemical or electrical signals to
initiate a cellular response (Martinac, 2014). Mechanosensitive (MS) ion channels are wellestablished as effectors of mechanosensation, and have been studied in a wide variety of
organisms and cell types (Brohawn, 2015). Two general models exist to describe the gating
behaviours of MS channels: the “bilayer mechanism” and the “tethered mechanism”. The
bilayer model describes MS channel activation as a direct result of membrane tension and
stretch. This form of gating is typically observed in bacterial channels, and does not require
any recruitment of additional intracellular components (Iscla & Blount, 2012). In contrast
to bacterial membranes, the lipid bilayer of animal cells is significantly more complex,
featuring folds and caveolae that buffer membrane tension and resist strain (Echarri & Del
Pozo, 2015). This gives rise to the “tethered model”, where force is indirectly applied to
MS channels via cytoskeletal, extracellular matrix (ECM), and accessory scaffolding
components (Hayakawa et al., 2008; Martinac, 2014). As external forces are applied to cell
membranes, they are transferred across the ECM to the cytoskeleton via membrane
spanning integrin proteins at focal adhesion sites (Geiger et al., 2009). Therefore,
investigations conducted in animal cells must consider the involvement of cytoskeletal
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actin and other structural components as routes of cellular force transmission and assess
their influence on ion channel mechanosensitivity.

1.6 Smooth Muscle Actin Dynamics
Actin is known to play both structural and functional roles in VSM. Cytoskeletal actin
maintains the shape and physical integrity of cells, while separate filaments assemble
around myosin to form the contractile apparatus (Tang & Anfinogenova, 2008). The
arrangement of actin is dynamic in smooth muscle, shifting between polymerized and
unpolymerized states. This process is commonly described with the filamentous (F) to
globular (G) actin ratio. Under resting conditions, a significant portion (~30%) of
unpolymerized G-actin is available for recruitment, with a reported F:G ratio of 2:1 (Cipolla
et al., 2002). Polymerization of G-actin into F-actin is known to occur in smooth muscle
following contractile stimuli and is thought to increase force generation; in tracheal smooth
muscle, stimulation with acetylcholine decreases G-actin content by 30% (Mehta & Gunst,
1999). Similar effects have been observed in carotid smooth muscle where norepinephrine
application increases the F:G ratio threefold (Tang & Tan, 2003). This process has been
deemed essential to myogenic tone development, as blockade of actin polymerization
abolishes pressure-induced constriction in cerebral arteries (Gokina & Osol, 2002).
Actin has also been studied in the context of ion channel regulation, though its effects are
less understood. Gokina and Osol observed enhanced Ca2+ influx and VSM depolarization
in pressurized cerebral arteries following actin disruption, however, the specific identity of
affected channels remained unclear (Gokina & Osol, 2002). Studies of mechanosensitive
Na+ channels in intestinal smooth muscle found that channels were coupled to the
cytoskeleton via scaffolding protein intermediates, and that this apparatus was required for
flow-induced activation (Ou et al., 2003). This finding not only highlights the importance
of the cytoskeleton for ion channel mechanosensing, but also the need for intermediate
proteins to facilitate actin binding. Members of the dystrophin associated protein complex
are often examined for such characteristics, as they primarily function to connect the actin
cytoskeleton to the membrane and ECM (Ehmsen et al., 2002).
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1.7 The Dystrophin Associated Protein Complex
Dystrophin is a large, 427 kDa cytoskeleton protein that assembles with syntrophin and
several other protein elements to form the dystrophin-associated protein complex (DAPC)
in various muscle tissues including VSM (Rivier et al., 1997; Ehmsen et al., 2002). The
loss of dystrophin through mutations in the DMD gene that encodes it produces a musclewasting disease known as Duchenne muscular dystrophy (DMD); its severe pathological
effects have prompted a great deal of research examining the functions of dystrophin and
its associated protein binding partners (Ohlendieck et al., 1993; Sadoulet-Puccio & Kunkel,
1996). Dystrophin spans actin filaments laterally, binding to them via its N-terminal
domain to form a physical connection with the cytoskeleton (Rybakova & Ervasti, 1997).
The C-terminus of dystrophin facilitates the assembly of the DAPC by providing binding
sites for syntrophin, sarcoglycan, dystroglycan, and dystrobrevin (Suzuki et al., 1992;
Ehmsen et al., 2002). Collectively, the DAPC anchors the actin cytoskeleton to the ECM
to reinforce the sarcolemma during muscle contraction and promote force transmission
across the membrane (Petrof et al., 1993; Rybakova & Ervasti, 1997). The absence of
dystrophin increases the likelihood of sarcolemmal rupture following contraction in
skeletal muscle, which produces the phenotype observed in DMD (Petrof et al., 1993). In
VSM, the loss of dystrophin has been demonstrated to decrease vessel contractility and
impair

stretch-induced

gene

transcription,

indicating

a

reduction

in

overall

mechanosensitivity (Turczyńska et al., 2015).

1.8 Syntrophins and KIR2.x Channels
Syntrophins are 58 kDa membrane-associated adaptor proteins known to participate in
DAPC formation and are also implicated in cell-signalling pathways (Constantin, 2014).
Five homologous syntrophin isoforms (α-1, β-1, β-2, γ-1, γ-2) exist and vary in their tissue
distributions. In muscle tissues, α-1 syntrophin is predominantly expressed where it
localizes at the sarcolemma and directly binds the C-terminus of dystrophin (Adams et al.,
1993; Ahn et al., 1996; Piluso et al., 2000). While syntrophins lack intrinsic enzyme
activity, they do possess unique protein-binding domains that allow them to localize other
protein components at the cell membrane to form signalling microdomains. Structurally,
all isotypes possess two pleckstrin-homology (PH) domains, the first of which contains a
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PDZ binding domain that facilitates protein-protein interactions while the second PH
domain binds with dystrophin (Ahn et al., 1996). PDZ binding domains are relatively
conserved regions of 80-100 amino acid residues that act as protein interaction modules to
bind short C-terminal PDZ motifs found on various cellular proteins (Harris & Lim, 2001).
Syntrophins contain a class I PDZ domain, which recognizes and binds protein targets
containing the C-terminal motif Ser/Thr-X-Φ-COOH, where X and Φ represent
interchangeable and hydrophobic residues respectively (Schultz et al., 1998). Through its
PDZ domain, syntrophin can facilitate a variety of protein-protein interactions with PDZ
motif containing partners to recruit signalling components to the DAPC. Among such
binding partners are KIR2.x channels: syntrophins recognize and bind KIR2.x subunits via
their C-terminal PDZ binding motif (Ser-Glu-Ile) (Leonoudakis et al., 2004). Through this
interaction, syntrophins may connect KIR channels directly to the DAPC to form a structural
link with the cytoskeleton. Proteomic analyses have identified KIR-syntrophin interactions
in heart, brain and skeletal muscle, however, our current understanding of their
physiological significance remains limited (Leonoudakis et al., 2004; Willis et al., 2015).

1.9 Caveolae as Signalling Microdomains
The clustering of signalling components with their protein targets enables rapid cellular
responses and is often achieved through distinct membrane structures known as caveolae
(Echarri & Del Pozo, 2015). Caveolae are cholesterol-enriched, flask-shaped membrane
invaginations found in a variety of mammalian cell types (Harvey & Calaghan, 2012). Their
curved structure is formed and stabilized by the insertion of caveolin proteins into the
membrane, of which three isoforms are known to exist. Caveolin-1 (cav1) and caveolin-2
(cav2) are expressed broadly across numerous tissues and cell types, whereas caveolin-3
(cav3) is found only in muscle cells (Hardin & Vallejo, 2006). All three isoforms have been
identified in VSM, though only the deletion of cav1 has been shown to limit caveolae
formation and weaken contractile responses (Drab et al., 2001; Hardin & Vallejo, 2006).
Functionally, caveolae have been found to play roles in lipid homeostasis, membrane
tension buffering, and signal complex formation (Sinha et al., 2011; Harvey & Calaghan,
2012; Fernández-Rojo et al., 2013). Caveolae enhance signalling cascades by concentrating
various elements such as ion channels, adaptor proteins, and receptors within microdomains
of the membrane (Echarri & Del Pozo, 2015). This is achieved in part through the
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interactions between signalling components and cav1. In addition to its structural role as a
molecular scaffold, cav1 is also known to directly regulate the activity of several channels
and enzymes. For example, swelling activated Cl- currents are suppressed in cav1 deficient
cell lines but are recovered by transient cav1 expression (Trouet et al., 1999). RhoA, a key
GTPase involved in myogenic Ca2+ sensitization, is also known to associate with caveolae.
In rat mesenteric arteries, both the translocation of RhoA to the membrane and its
subsequent pressure-induced activation are attributed to interactions with cav1 (Dubroca et
al., 2007).
Actin filaments are also known to associate with caveolae, as co-localization has been
reported in several cell types including smooth muscle (Brainard et al., 2005; Echarri &
Del Pozo, 2015). Actin is thought to anchor and stabilize caveolae, as depolymerization of
the cytoskeleton can cause cav1 movement throughout the cell (Echarri & Del Pozo, 2015).
The association between caveolae and actin also creates a highly effective
mechanotransduction domain, providing a focal point where mechanical inputs can be
directed. This mechanism has been considered in the context of stretch-activated Ca2+
channels, of which some isoforms reside in caveolae and also rely on the cytoskeleton for
tension detection (Gervasio et al., 2008; Ito et al., 2010; Echarri & Del Pozo, 2015).
Interestingly, KIR2.x channels are also known to reside in caveolae structures in VSM cells
(Sancho et al., 2019). In a similar manner to stretch-sensitive Ca2+ channels, the localization
of KIR2.x channels within caveolae may also enhance their mechanosensitivity.
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1.10 Study Rationale, Aims and Hypotheses
The overall goal of this thesis is to further elucidate the role that smooth muscle KIR2.x
channels play in myogenic tone development of cerebral arteries. To accomplish this, two
studies will be conducted to provide detail where knowledge gaps exist.
The first study will address the overall contribution of the KIR2.1 subunit towards cerebral
blood flow responses using a smooth muscle specific KIR2.1-/- mouse. Given the emphasis
that has been placed on the KIR2.1 subunit for providing the native inward K+ current in
vascular smooth muscle (Bradley et al., 1999; Zaritsky et al., 2000), we expect a dramatic
loss of KIR activity and its associated vascular functions following genetic knockout. Global
deletion of KIR2.1 proved to be lethal in prior studies, and therefore observations have been
limited to neonates. Our use of a conditional knockout model will allow for observations
to be made in adult animals, thus enabling a more comprehensive examination of channel
function than was previously possible.
The second project will explore the signalling processes underlying smooth muscle KIR
pressure sensitivity in cerebral arteries. Guided by established models of ion channel
mechanosensitivity (Harris et al., 2018), we predict that KIR2.x channels interact with the
actin cytoskeleton as a means of detecting mechanical forces. Previously reported
interactions between KIR2.x channels with syntrophin and caveolin make these scaffolding
proteins likely candidates for mediating such actin interactions, and will be assessed in
vascular smooth muscle cells (Leonoudakis et al., 2004; Sancho et al., 2019). Experiments
will seek to perturb these structures in isolated cells and observe the impact towards KIR
activity during mechanical stimulation.
The specific aim of each study is stated below:
Project 1:
Aim: Determine the impact of smooth muscle KIR2.1 disruption within the cerebral
vasculature.
Hypothesis: Removal of the dominant KIR2.1 subunit will eliminate the majority of inward
K+ conductances in VSM and their associated vascular responses.
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Project 2:
Aim: Identify cellular components that enable KIR2.x pressure-sensing in vascular smooth
muscle.
Hypothesis: VSM KIR2.x pressure sensitivity is dependent on physical connections to the
actin cytoskeleton which are mediated by scaffolding proteins.
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Chapter 2:
Genetic Ablation of Smooth Muscle KIR2.1 is Inconsequential to the
Function of Mouse Cerebral Arteries
2.1 Introduction
Cerebral blood flow (CBF) is maintained by a network of resistance arteries that match red
blood cell delivery with tissue demand (Segal & Duling, 1986; Zechariah et al., 2020). The
vascular smooth muscle (VSM) layer translates vasoactive stimuli into diameter changes,
allowing for the precise tuning of blood flow needed for optimal brain function (Knot et
al., 1996; Knot & Nelson, 1998; Zhang et al., 2002). Smooth muscle cell (SMC)
contractility is tightly coupled to intracellular [Ca2+], an essential secondary messenger that
sets myosin light chain phosphorylation and consequently the extent of cross-bridge cycling
(Cole & Welsh, 2011). The influx of extracellular Ca2+ is facilitated by voltage-gated Ca2+
channels (VGCCs), integral membrane proteins whose activity is coupled to arterial
membrane potential (VM) (Thorneloe & Nelson, 2005). It is this balance of inward
depolarizing currents and outward hyperpolarizing currents that determine VM in smooth
muscle. The latter is largely delivered through membrane-embedded K+ channels,
including voltage-gated (KV), ATP-sensitive (KATP), Ca2+-activated, and inwardly
rectifying (KIR) channels (Nelson & Quayle, 1995).
In cerebral arteries, KIR channels are major contributors to the development of myogenic
tone (Quayle et al., 1997). They exist as tetrameric assemblies of 4 α-subunits from the
strong-rectifying KIR2.x subfamily, of which KIR2.1 is thought to be the predominant
subunit in SMCs (Bradley et al., 1999; Hibino et al., 2010). KIR channels possess several
unique electrical characteristics including inward rectification at membrane potentials
negative to EK, activation by extracellular K+, and rapid blockade by micromolar Ba2+
(Quayle et al., 1993; Shieh et al., 1998). At a functional level, these properties enable KIR
channels to participate in K+-induced dilation, vessel hyperpolarization, and hemodynamic
force sensing (Knot et al., 1996; Wu et al., 2007; Sancho et al., 2019). Interestingly, KIR2.2
subunits have also been identified in cerebral vessels and are thought to form functional
channels when heteromultimerized with KIR2.1 (Schram et al., 2003; Sancho et al., 2019).
This knowledge raises the question of the overall contribution of KIR2.1 to native currents
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and their associated functions in SMCs of cerebral arteries. Early studies addressed this
question and demonstrated a role for KIR2.1 in cerebral SMCs from a global KIR2.1
knockout mouse (Bradley et al., 1999; Zaritsky et al., 2000). While these reports provided
great insight, the lethality of gene deletion limited experimentation to neonates. Thereafter,
research examining cerebral KIR channels has focused on KIR2.1 as the dominant subtype
responsible for inward K+ conductances in cerebral SMCs despite limited evidence in adult
animals. Advancements in genomic techniques have since overcome previous limitations
of KIR2.1 knockout, providing an opportunity to pursue a more comprehensive
understanding of the channel’s role in the cerebral circulation.
Our work addressed outstanding uncertainties surrounding cerebral KIR2.1 function using
an adult tamoxifen-induced SMC-specific KIR2.1 conditional knockout model.
Preparations

progressed

from

isolated

cells

to

live

animals

and

employed

electrophysiology, immunocytochemistry, and arterial spin-labelling magnetic resonance
imaging techniques. Contrary to expectations, robust currents were observed in SMCs
despite KIR2.1 knockout. Further immunolabelling revealed that, while KIR2.1 was
significantly reduced by conditional knockout, its low abundance in control animals
suggests a weak phenotype. However, in search of other KIR subunits, KIR2.2 was found
abundantly concentrated at the SMC plasma membrane. At the live animal level, brain
perfusion remained unaffected by knockout and responses to blood pressure elevation were
unchanged. Taken together, these findings indicate that inward K+ currents in cerebral
arterial myocytes are likely derived from subunits other than KIR2.1.
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2.2 Methods
2.2.1. Animal Models & Procedures
All animal procedures followed regulations set by the Canadian Council of Animal Care
and were approved by the University of Western Ontario Animal Care Committee (Protocol
#2017-144). Colonies were maintained at the University of Western Ontario under constant
room temperature and humidity environment with a 12-hr light/dark cycle and allowed ad
libitum access to food and water. SMMHC-CreERT2 male mice, strain B6.FVB-Tg(Myh11cre/ERT2)1Soff/J, were provided by Dr. Mark Nelson (University of Vermont, Burlington,
VT, USA). The SMMHC-CreERT2 mice, which express a Cre recombinase under control
of the smooth muscle myosin, heavy polypeptide 11, smooth muscle (Myh11) promoter on
the Y chromosome, were crossed with floxed KIR2.1 mice (strain B6.Cg-Kcnj2tm1swz) to
produce tamoxifen-inducible SMC KIR2.1-/- male mice. The mice (at 6 weeks of age) were
treated with tamoxifen by oral gavage (0.12 mg kg-1 in corn oil; Sigma-Aldrich, Oakville,
ON, Canada) once daily for 5 days to induce the SMC-specific knockout of KIR2.1 via the
tamoxifen-mediated nuclear translocation of Cre recombinase. Non-induced mice served
as control animals. ARRIVE guidelines for reporting animal research were followed
(Kilkenny et al., 2010).
2.2.2. Vessel Collection
SMC KIR2.1-/- mice were euthanized via CO2 asphyxiation 2 – 3 months after tamoxifen
treatment with age-matched controls. The brain was removed and placed in chilled
phosphate-buffered solution (PBS; pH 7.4) containing (in mM): 138 NaCl, 3 KCl, 10
Na2HPO4, 2 NaH2PO4, 5 glucose, 0.1 CaCl2, and 0.1 MgSO2. Cerebral and cerebellar
arteries were carefully dissected and cleaned for further enzymatic digestion. All solution
chemicals were purchased from Sigma Aldrich (Ontario, Canada) unless otherwise stated.
2.2.3. Isolation of Arterial Smooth Muscle Cells
Dissected arteries were enzymatically digested to yield isolated smooth muscle cells using
a two-step process (Nieves-Cintrón et al., 2018). Briefly, vessel segments were placed in
isolation medium containing (in mM): 60 NaCl, 80 sodium glutamate, 5 KCl, 2 MgCl2, 10
glucose and 10 HEPES with 1 mg ml-1 bovine serum albumin (pH 7.4), and chilled on ice
for 10 minutes before the reaction began. Following an initial warming period (37 ºC, 10
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minutes), vessels underwent a two-step digestion process: 1) a 6-minute incubation in
isolation medium containing 0.9 mg ml-1 papain and 1 mg mL-1 dithiothreitol and 2) a 7minute incubation in isolation medium containing 0.3 mg mL-1 H-type collagenase, and 0.7
mg mL-1 F-type collagenase. Following enzyme incubations, vessels were thoroughly
washed with ice-cold isolation medium and allowed to rest on ice for 30 minutes before
disruption with a fire-polished pipette. Isolated cells were used same day for
electrophysiology or immunofluorescence experiments.
2.2.4. Electrophysiology
Whole-cell patch clamp electrophysiology was used to measure Ba2+-sensitive KIR currents
in isolated smooth muscle cells. Recording electrodes were pulled from borosilicate glass
(Sutter Instruments, Novato CA) using a micropipette puller (Narishige PP-830, Tokyo,
Japan), fire-polished (Narishige MF-830, Tokyo, Japan) and filled with pipette solution
containing (in mM): 5 NaCl, 35 KCl, 100 K-gluconate, 1 CaCl2, 0.5 MgCl2, 10 HEPES, 10
EGTA, 2.5 Na2-ATP, 0.2 GTP (pH 7.2). Whole-cell access was obtained by placing the
pipette onto a cell and applying negative pressure until membrane rupture occurred. Cells
were then voltage clamped at -50 mV and equilibrated in a bath solution containing (in
mM): 140 NaCl, 5 KCl, 0.5 MgCl2, 10 HEPES, 10 glucose and 0.1 CaCl2. To stimulate KIR
activity, extracellular K+ was increased with a bath solution containing (in mM): 60 KCl,
85 NaCl, 0.5 MgCl2, 10 HEPES, 10 Glucose, and 0.1 CaCl2 (pH 7.4). Voltage was then
stepped to -100 mV for 100 ms and subsequently ramped to +20 mV at a rate of 0.04 mV
ms-1. Ba2+ (100 µM), a selective inhibitor of KIR channels, was then added to the bath to
distinguish KIR activity from whole-cell currents. Currents were recorded on an Axopatch
200B amplifier (Molecular Devices, Sunnydale CA), with signals filtered at 1 kHz and
digitized at 5 kHz. Data was extracted and analysed using Clampfit 10.3 software
(Molecular Devices, Sunnydale CA). Cell capacitance ranged from 10 to 16.5 pF as
measured by the amplifier. A 1 M NaCl-agar salt bridge was added between the reference
electrode and the bath solution to minimize offset potentials. All experiments were
performed at room temperature (22 ºC).
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2.2.5. Immunofluorescence
Isolated cerebral smooth muscle cells from non-induced control and SMC KIR2.1-/- mice
were probed for KIR2.1 and KIR2.2 protein expression. Cells were settled onto poly-L-lysine
treated coverglass and fixed in 4% paraformaldehyde (15 min, 22 ºC). Fixed cells were then
washed 3 times with PBS prior to permeabilization with 0.2% Tween 20 (15 min, 22 ºC).
A quench solution containing 0.2% Tween 20 and 3% donkey serum was used to block
cells for one hour (22 ºC). Rabbit polyclonal primary antibodies against KIR2.1 (Alomone,
Jerusalem, Israel, APC-026; 1:200) and KIR2.2 (Alomone, APC-042; 1:200) were diluted
in quench solution and applied to cells for an overnight incubation (4 ºC). The next day
cells were washed with 0.2% Tween 20 and treated with Alexa Fluor® 488 donkey antirabbit IgG (ThermoFisher Scientific, Ontario, Canada, A-21206; 1:1000) fluorophoreconjugated secondary antibodies (1 hour, 22 ºC). After additional washes, cells were
mounted to slides with ProLong™ Diamond Antifade Mountant (ThermoFisher Scientific)
with DAPI. Images of immunostaining were captured using a Leica-TCS SP8 confocal
microscope with a 63× oil-immersion lens. Laser intensity was increased to visualize
KIR2.1 staining as its low expression generated a weak fluorescent signal. Controls for each
stain were prepared by removing the primary antibody from the assay. Mean stain
fluorescence of each cell was measured using Image-J software and background signal was
subtracted using 2º antibody controls.
2.2.6. Arterial Spin-Labelling Magnetic Resonance Imaging:
Under 2% isoflurane anesthesia, a polyethylene catheter (PE10; Instech Laboratories,
Plymouth Meeting, PA, USA) was implanted intraperitoneally and connected to a syringe
containing 1 mM phenylephrine. The animal was placed in a custom-built insert in the
prone position and inserted in an Agilent Animal MRI scanner with a 9.4-Tesla, 31-cm
horizontal bore magnet (Magnex Scientific, Yarton, UK), 60-mm gradient coil set of
1000mT/m strength (Agilent, Palo Alto, CA, USA), and Bruker Avance MRI III console
with Paravision-6 software (Bruker BioSpin Corp, Billerica, MA, USA). A 40-mm
millipede volume coil (Agilent, Palo Alto, CA, USA) was used for data acquisition.
An anatomical reference scan was acquired using a 2D fast spin echo (Turbo-Rapid
Acquisition with Relaxation Enhancement (RARE)) sequence with the following
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parameters: field of view (FOV) = 19.2 × 19.2 mm2, matrix size = 128 × 128, 11 slices
with slice thickness of 1 mm, repetition time (TR) = 5000 ms, echo time (TE) = 10 ms,
effective echo time (TEeff) = 40 ms, RARE factor = 8, number of averages (NA) = 1.
A flow-sensitive alternating inversion-recovery spin echo planar imaging sequence with a
180° hyperbolic secant radiofrequency inversion pulse was used (imaging parameters: TE
= 17 ms; 5 slices with imaging slice thickness of 2 mm; image matrix = 64 × 50; FOV =
19.2×15 mm2, inversion parameters: inversion slab thickness = 13 mm; pulse length = 3
ms) for perfusion images. Eleven images with increasing inversion times (TIs) (100
ms+i⁎300 ms (i=0, 2, 3, ..., 10)) were obtained for each slice to determine T1. Images with
slice selective inversion were acquired followed by images with nonselective inversion.
From these images, T1sel and T1nonsel were calculated using a non-linear least square fit
(ASL-Perfusion Processing; Bruker). The five 2-mm slices spanned the mouse brain with
a total scan time of approximately 13 min.
During acquisition, the animal was maintained at 1.7% isoflurane and breath rate was
monitored (PC-SAM model #1025; SA Instruments, Inc., Stony Brook, NY, USA) with a
pneumatic pillow. Body temperature was measured with a rectal probe and maintained at
approximately 37 ºC with a homeothermic warm air blower. Mean arterial pressure (MAP)
was measured with a tail cuff (CODATM Monitor, Kent Scientific, Torrington, CT, USA)
during MRI acquisition. After a baseline scan of the brain was acquired, phenylephrine
hydrochloride (0.816 mg kg-1; Sigma-Aldrich, Oakville, ON, Canada) was injected and the
scan was repeated. Following completion of MRI, mice were euthanized via cervical
dislocation under deep anesthesia. All animals survived the imaging procedure but one
mouse in the control group was excluded from experimental analysis due to heating
equipment malfunction during data acquisition. CBF (mL/100 g/min) was quantified in the
cortex, cerebral nuclei, hippocampus, thalamus, hypothalamus and midbrain using custom
software written in MATLAB (Mathworks, Inc., Natick, MA, USA).
2.2.7. Statistical Analysis
Data are expressed as mean ± SEM. For patch and immunofluorescence experiments, n
indicates the number of cells and unpaired t-tests were used to compare differences between
control and tamoxifen-induced knockout groups. For isolated cell techniques, no more than
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two experiments were performed on cells collected from a single animal. For MRI-ASL
experiments, differences in brain perfusion between controls and knockout mice were
assessed with an unpaired t-test and response to phenylephrine challenge was analyzed with
a paired t-test. Analysis was conducted using GraphPad Prism 8 (GraphPad Software; La
Jolla, CA, USA). P < 0.05 was considered statistically significant.
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2.3 Results
2.3.1. KIR Currents Persist Beyond KIR2.1 Knockout in Cerebral Smooth Muscle
In cerebral arterial smooth muscle, KIR2.1 subunits are presumed to be the dominant
isoform driving the native KIR2.x current (Bradley et al., 1999). To explore this concept,
initial experiments sought to delineate the impact of KIR2.1 knockout on whole-cell Ba2+
sensitive inward rectifying K+ currents in freshly isolated smooth muscle cells. Figure 2.1
denotes the presence of a robust inward current in both tamoxifen-induced SMC KIR2.1-/and non-induced control animals. The observed currents were readily activated by
extracellular K+ and blocked by micromolar Ba2+, signature characteristics of vascular
KIR2.x channels. On aggregate, Ba2+-sensitive currents were modestly reduced in tamoxifen
induced SMC KIR2.1-/- mice (5.83 ± 0.63 pA/pF) compared to non-induced controls (7.12
± 0.88 pA/pF) but this comparison was not significantly different (Figure 2.1C).
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Figure 2.1: Genetic ablation of KIR2.1 does not eliminate inward K+ currents in
cerebral smooth muscle cells. Whole-cell patch clamp electrophysiology was used to
measure KIR current with voltage ramps from -100 to +20 mV in the absence and presence
of Ba2+. (A and B) Representative recordings of whole-cell and Ba2+-subtracted KIR
currents in smooth muscle cells isolated from SMC KIR2.1-/- mice and non-induced controls.
(C) Summary data comparing peak inward current at -100 mV between groups (unpaired
t-test, n = 9 cells/group). Data expressed as mean ± SEM.
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2.3.2. KIR2.1 Expression was Reduced Post-Knockout in Cerebral Arterial Myocytes
without Impacting KIR2.2.
The whole-cell currents we observed, while indicative of strong rectifying KIR2.x activity,
likely exist as a composite of all KIR2.x channels expressed in VSM. Therefore, to further
discern the contributions of individual KIR2.x subunits, we screened for subunits commonly
described in cerebral arterial smooth muscle—KIR2.1 and KIR2.2 (Sancho et al., 2019).
Immunostaining for KIR2.1 revealed a diffuse expression pattern that was weakly
associated with the plasma membrane (Figure 2.2A). Mean global cell fluorescence of
KIR2.1 antibody signal was reduced in the tamoxifen-induced SMC KIR2.1-/- mice when
compared with the non-induced group (Figure 2.2B). In contrast, KIR2.2 was
predominantly concentrated at the plasma membrane (Figure 2.3A) and the induction of
KIR2.1 knockout did not impact its expression, as shown through a comparison of mean
global cell fluorescence (Figure 2.3B). While contrary to initial reports (Bradley et al.,
1999; Zaritsky et al., 2000), this expression pattern aligns with recent molecular work
highlighting KIR2.2 dominance over KIR2.1 at the mRNA level in mouse cerebral arterial
smooth muscle cells (Figure 2.4).
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Figure 2.2: KIR2.1 is negligibly expressed in control smooth muscle cells. Tamoxifeninduced KIR2.1 knockout significantly reduced subunit expression but levels remained
detectable by immunofluorescence. (A) Fluorescent antibody staining of cerebral smooth
muscle cells from SMC KIR2.1-/- and control mice for KIR2.1 (green) and nuclei stained with
DAPI (blue). (B) Summary data comparing fluorescence intensity (background subtracted)
of KIR2.1 signal between groups (n = 10 cells pooled from 5 animals/group, unpaired ttest). Two cells were analyzed per animal with background signal subtracted using 2º
antibody control. Data expressed as mean ± SEM, *p < 0.05 compared with Cre SMC
control.

Figure 2.3: KIR2.2 is highly expressed in cerebral arterial smooth muscle and
knockout of KIR2.1 does not interfere with KIR2.2 protein expression. (A)
Immunofluorescence staining of cerebral smooth muscle cells from SMC KIR2.1-/- and
control mice for KIR2.2 (green) with nuclei stained with DAPI (blue). (B) Summary data
comparing fluorescence intensity (background subtracted) of KIR2.2 signal between groups
(n = 8 cells pooled from 4 animals/group, unpaired t-test). Two cells were analyzed per
animal with background signal subtracted using 2º antibody control. Data expressed as
mean ± SEM.
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Figure 2.4: KIR2.1 and KIR2.2 subunits are inversely expressed in endothelial and
vascular smooth muscle cells. (A) KIR2.1 and (B) KIR2.2 subunit expression is shown as
average cellular transcript counts per cell as determined by single-cell RNA sequencing of
the mouse brain vasculature. Data above highlights differences in the dominant subunit
between cell types. Abbreviations: PC - pericytes; SMC - smooth muscle cells; EC endothelial cells; v - venous; c - capillary; a - arterial; aa - arteriolar. Figures provided by
http://betsholtzlab.org/VascularSingleCells/database.html (Vanlandewijck et al., 2018; He
et al., 2018).
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2.3.3. Region-Specific Brain Perfusion is Unaltered in SMC KIR2.1-/- mice.
Functional hyperemia in the brain, often termed neurovascular coupling, has been linked
to the activation of SMC KIR by extracellular K+ (Filosa et al., 2006). These channels have
also been implicated in cerebral autoregulation as they can respond to changes in
intravascular pressure (Sancho et al., 2019). Considering these functions, we assessed the
effects of SMC-specific KIR2.1 knockout on cerebral perfusion at rest and in response to a
systemic blood pressure challenge. Animals were instrumented and placed in an MRI
scanner for blood flow measurement by ASL before and after intraperitoneal phenylephrine
injection. At rest, there were no significant differences between control and SMC KIR2.1-/mice in perfusion of the cortex, cerebral nuclei, hippocampus, thalamus, hypothalamus, and
midbrain (Figure 2.5 and 2.6). Phenylephrine injection increased MAP from 98.9 ± 5.6
mmHg to 109.3 ± 6.2 mmHg (P < 0.05). Of note, MAP did not differ between the two
groups of mice and so the results were pooled. The phenylephrine treatment resulted in a
small but significant rise in CBF in all the brain regions analyzed (Figure 2.5 and 2.6).
However, the magnitude of this response did not differ between the two groups (Figure
2.6).
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Figure 2.5: Representative arterial spin-labelled MR brain perfusion maps.
Scans were done in a posterior-to-anterior direction and the volume of brain scanned was
divided into 5 coronal slices (red boxes). Baseline perfusion was measured in control and
SMC KIR2.1-/- mice and scans were repeated after intraperitoneal phenylephrine challenge.
Figure shows slices from 2 regions of the brain spanning cerebral nuclei, hippocampus,
thalamus, and hypothalamus. The perfusion maps were comparable between the two groups
of mice.
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Figure 2.6: Region-specific brain perfusion is not altered in SMC KIR2.1-/- mice at rest
and with increased systemic blood pressure. Resting cerebral blood flow in several major
brain structures was not significantly different between control and tamoxifen-induced
mice. To further determine whether cerebral blood flow regulation is altered with SMC
KIR2.1 knockout, systemic blood pressure was elevated with intraperitoneal phenylephrine
infusion and brain scans were repeated. The blood pressure challenge caused a modest but
significant rise in cerebral blood flow to a similar extent in control and SMC KIR2.1-/animals. Unpaired t-test performed for control (n = 7 mice) vs. SMC KIR2.1-/- (n = 11 mice)
comparison; paired t-test performed for baseline vs. phenylephrine-treatment perfusion
maps. Data expressed as mean ± SEM, *p < 0.05 compared to baseline control.

29

2.4 Discussion
2.4.1. Overview
This study explored the role that KIR2.1 plays within the cerebral vasculature using an
inducible, cell-specific genetic knockout model. The persistence of K+ currents following
knockout of KIR2.1 raised the possibility that other subunits underlie the smooth muscle
inward K+ conductance. Functional experiments further reinforced this idea as SMC
expression of KIR2.1 was not required for myogenic reactivity of cerebral arteries and
maintenance of blood flow to various regions of the brain. High expression of KIR2.2
subunits, as detected by immunofluorescence and RNA sequencing in myocytes, may
account for this lack of phenotype. These findings highlight that cerebral KIR responses are
not dependent on KIR2.1 and suggest that the native channel pool may be more
heterogenous in composition than previously thought.
2.4.2. KIR Channels in Vascular Smooth Muscle
Contractility of the VSM layer is tightly coupled to intracellular Ca2+ sourced through
VGCCs, thereby creating a close relationship between VM and diameter (Thorneloe &
Nelson, 2005). K+ channels regulate the influx of Ca2+ by hyperpolarizing VM to promote
relaxation and vasodilation (Nelson & Quayle, 1995). The strong-rectifying KIR2.x family
of channels are especially prominent within cerebral vessels where they are active under
basal conditions to hyperpolarize VM (Nelson & Quayle, 1995; Smith et al., 2008; Sancho
et al., 2019). Although their role appears subtle, altering KIR activity translates to significant
effects on vessel diameter and reactivity. Channel inhibition with Ba2+ causes
vasoconstriction, reduces flow, and prevents K+-induced dilation in rat cerebral and human
brachial arteries (Knot et al., 1996; Dawes et al., 2002; Wu et al., 2007). KIR modulation
by hemodynamic forces has also been reported, with recent work demonstrating their
sensitivity to pressure and flow in vascular smooth muscle and endothelium, respectively
(Wu et al., 2007; Sancho et al., 2019). This is intriguing as it implicates KIR as a mediator
of arterial tone development and blood flow control. Building upon these observations, it
is reasonable to predict that channel knockout would weaken myogenic responses and
reduce control of tissue perfusion in vascular networks where the channel is well expressed.
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2.4.3. Persistent KIR Activity and Molecular Composition
This study began by examining native KIR currents in vascular smooth muscle isolated from
cerebral arteries. To our surprise, comparable KIR activity was detected in both SMC
KIR2.1-/- and non-induced control mice (Figure 2.1). While currents trended slightly lower
in KIR2.1-/- animals, no significant difference was observed between the two groups. These
findings

suggest

that

another

KIR

subunit

is

expressed—one

with

similar

electrophysiological properties. Based on Ba2+ sensitivity and unitary conductance, KIR2.2
is a logical target and it should be noted that this subunit can heteromultimerize with KIR2.1
(Liu et al., 2001; Schram et al., 2003). With this in mind, we sought to observe the
localization of key KIR subunits in cerebral arterial smooth muscle cells. Antibodies
revealed a punctate labeling pattern for KIR2.1 that was weak in control mice and was
further diminished after knockout. As to other pertinent KIR subunits, we found that KIR2.2
is abundantly concentrated at the SMC plasma membrane. While these results contradict
the historical view of KIR2.1 being the dominant subtype in cerebral SMCs, they do align
with recent reports of single-cell RNA sequencing of cerebrovascular cells (Vanlandewijck
et al., 2018; He et al., 2018). Specifically, this transcriptomic analysis revealed that KIR2.1,
while being highly expressed in endothelial cells, was decidedly less abundant in arteriolar
SMCs (Vanlandewijck et al., 2018; He et al., 2018). Conversely, KIR2.2 mRNA expression
was greater in SMCs but negligible in ECs. This differential expression pattern, in concert
with our functional data, reinforces the notion that the expression of KIR2.1 in SMCs is not
central to cerebral vessel function.
2.4.4. Functional Impact of KIR2.1 Disruption
As previously described, smooth muscle KIR channels are sensitive to hemodynamic forces;
as intraluminal pressure rises, their activity is suppressed and KIR currents are diminished
(Wu et al., 2007; Sancho et al., 2019). These results also align with increased Ba2+
sensitivity—reflective of greater KIR activity—of intact cerebral arteries at lower pressures
(Sancho et al., 2019). Based on this trait, we anticipated that mice deficient in smooth
muscle KIR2.1 would exhibit diminished myogenic responses to pressure. The resulting
impairment of cerebral blood flow regulation would manifest as enhanced brain perfusion
on the ASL perfusion maps. However, in our study, region-specific brain perfusion was
comparable between SMC KIR2.1-/- mice and controls. Likewise, a phenylephrine-induced
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blood pressure challenge did not alter cerebral autoregulation among the two groups. This
implies a limited role for KIR2.1 in conferring pressure sensitivity in the cerebral
vasculature and is therefore not a driver of tone development.
2.4.5. Summary
Historically, KIR2.1 was viewed as a major contributor to cerebral SMC inward K+ currents.
Our observations lie in contrast, with KIR activity persisting at the isolated cell and live
animal levels after the induction of an SMC-specific KIR2.1 knockout. The lack of
functional impact following knockout in our study suggests that KIR2.1 is either a redundant
component of the KIR pool or, perhaps, is of no functional significance in this cell type.
Indeed, we found that KIR2.1 expression in SMCs is modest, while a different subunit—
KIR2.2—was found abundantly localized to the plasma membrane. To summarize, these
findings prompt the vascular ion channel field to reconsider its position on the relevance of
KIR2.1 with respect to other KIR subunits in cerebral SMCs.
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Chapter 3:
The KIR Mechanotransduction Complex in Cerebrovascular
Smooth Muscle
3.1 Introduction
Cerebral arteries adjust their diameter in response to rising intraluminal pressure to
maintain steady tissue perfusion (Bevan & Laher, 1991; Golding et al., 1998). This process
is known as the myogenic response, and is initiated by depolarization of the vascular
smooth muscle (VSM) layer of the arterial wall (Davis & Hill, 1999). Ion channels present
in VSM set membrane potential (VM) to regulate the entry of contractile Ca2+ through
voltage-gated Ca2+ channels (VGCCs), effectively coupling vessel diameter to voltage
(Knot & Nelson, 1998; Thorneloe & Nelson, 2005). Several channels expressed in VSM
also exhibit mechanosensitivity, and are thought to drive early depolarization to initiate the
myogenic response (Thorneloe & Nelson, 2005).
Mechanosensation is defined as the conversion of physical stimuli to intracellular signals
and is critical to many physiological functions including the myogenic response (Davis &
Hill, 1999; Brohawn, 2015). Pressure augments the activity of several ion channels found
in VSM including non-selective transient receptor potential cation (TRPC) and chloride
(Cl-) channels, and more recently, inwardly rectifying potassium (KIR) channels (Nelson et
al., 1997; Welsh et al., 2000; Earley et al., 2004; Wu et al., 2007). KIR channels are wellexpressed in cerebral arterial myocytes and consist primarily of KIR2.x subunits from the
strong-rectifying family (Bradley et al., 1999; Smith et al., 2008). Functionally, KIR
channels are described as a background conductance as they pass K+ current under resting
conditions to maintain VM hyperpolarization. Recently, work has expanded our
understanding of smooth muscle KIR function by demonstrating their sensitivity to pressure
(Wu et al., 2007; Sancho et al., 2019). While intriguing, our mechanistic understanding of
this response remains limited.
Classic models of mechanosensitivity often cite the involvement of the cytoskeleton as a
means of transmitting force to membrane bound ion channels (Hayakawa et al., 2008;
Martinac, 2014). While KIR 2.x channels are unable to bind actin directly, they are known
to interact with cytoskeleton-associated proteins through a three amino acid PDZ binding
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motif (amino acids Ser-Glu-Ile) present at their C-terminus (Leonoudakis et al., 2001,
2004). Such interactions have been found to favor the KIR2.2 subunit in particular, binding
with greater affinity thus making it an ideal site for signal complex formation (Leonoudakis
et al., 2004). Among these binding partners is syntrophin, a member of the dystrophin
associated protein complex (DAPC) which serves to connect the actin cytoskeleton to the
plasma membrane and extracellular matrix (Ehmsen et al., 2002; Iwata et al., 2004). While
the

physiological

importance

of

this

interaction

remains

unclear,

it

is

possible that syntrophins couple KIR channels with the cytoskeleton to enable their force
sensitivity. Furthermore, arterial KIR channels reside in caveolae—specialized flask shaped
structures present in the membrane of VSM cells (Sancho et al., 2019). Caveolae are also
thought to play a role in mechanotransduction pathways by providing a platform for
signalling complex assembly and further attachment points for actin (Harvey & Calaghan,
2012; Echarri & Del Pozo, 2015). Investigating the relationship between these protein
structures and KIR channels may provide insight towards their mechanosensitivity in VSM.
This study explored how interactions between KIR channels and structural proteins
mediate mechanosensation in rat cerebral arterial myocytes. Experiments were conducted
using cells isolated from native tissue and incorporated electrophysiology and molecular
techniques. Initial patch clamp electrophysiology confirmed that pressure, initiated by
a hyposmotic challenge, suppresses KIR activity in isolated cells. This response was
abolished by pre-treatment with actin-disrupting agents. In a similar manner, blockade of
caveolae-forming proteins also prevented KIR suppression during cell-swelling. Work next
examined the expression and organization of caveolin-1 (cav1) and syntrophin, proteins
known to interact with KIR subunits and actin. Immunofluorescence highlighted the
expression of both syntrophin and cav1 in VSM, while proximity ligation assay revealed
their co-localization with KIR2.2 subunits. These findings provide evidence that
KIR mechanosensitivity involves interactions with the cytoskeleton which are likely
mediated by scaffolding proteins.
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3.2 Materials & Methods
3.2.1. Animal Procedures
All animal procedures were approved by the University of Western Ontario Animal Care
Committee in accordance with the Canadian Council on Animal Care. Female SpragueDawley rats, between 10 to 12 weeks of age, were euthanized via CO2 asphyxiation. Female
rats were selected as cell isolation procedures yield a greater quantity of robust cells for
electrophysiology experiments. The brain was then removed and placed in chilled
phosphate-buffered solution (PBS) (pH 7.4) containing (in mM): 138 NaCl, 3 KCl, 2
NaH2PO4, 10 Na2HPO4, 5 glucose, 0.1 MgSO4 and 0.1 CaCl2. Middle and posterior cerebral
and cerebellar arteries were then dissected, cleaned, and cut into 2 mm segments for
enzymatic digestion.
3.2.2. Isolation of Arterial Smooth Muscle Cells
Dissected arteries were enzymatically digested to yield isolated smooth muscle cells.
Vessel segments were placed in an isolation medium (37 ºC, 10 min) containing (in mM):
80 sodium glutamate, 5 KCl, 60 NaCl, 2 MgCl2, 10 glucose, 10 HEPES and 1 mg mL-1
bovine serum albumin (pH 7.4). Vessels were then settled on ice for 10 minutes before
warming to 37 ºC for a two-step digestion process: 1) a 13-15 minute incubation in isolation
medium containing 0.6 mg mL-1 papain and 1.5 mg mL-1 dithiothreitol, and 2) a 10-minute
incubation in isolation medium containing 100 μM Ca2+, 0.3 mg mL-1 H-type collagenase,
and 0.6 mg mL-1 F-type collagenase. Following enzyme incubations, vessels were
thoroughly washed with ice-cold isolation medium and gently disrupted with a firepolished Pasteur pipette to dissociate cells. Isolated cells were used same day for
electrophysiology, immunofluorescence staining, or proximity ligation assay.
3.2.3. Electrophysiology
Whole-cell patch clamp electrophysiology was used to measure KIR currents in isolated
smooth muscle cells. Recording electrodes were pulled from borosilicate glass (Sutter
Instruments, Novato CA) using a micropipette puller (Narishige PP-830, Tokyo, Japan),
fire-polished (Narishige MF-830, Tokyo, Japan ) and filled with pipette solution containing
(in mM): 5 NaCl, 35 KCl, 100 K-gluconate, 1 CaCl2, 0.5 MgCl2, 10 HEPES, 10 EGTA,
2.5 Na2-ATP, 0.2 GTP (pH 7.2). Whole-cell access was attained by placing the pipette onto
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the cell and applying negative pressure until membrane rupture occurred. Currents were
recorded on an Axopatch 200B amplifier (Molecular Devices, Sunnydale CA) and
processed using Clampfit 10.3 software (Molecular Devices, Sunnydale CA). Cells were
then voltage clamped at -50 mV and held in a bath solution containing (in mM): 140 NaCl,
5 KCl, 0.5 MgCl2, 10 HEPES, 10 glucose and 0.1 CaCl2 (pH 7.4) for 5 minutes. To
stimulate KIR activity, extracellular K+ was increased with a bath solution containing (in
mM): 75 NaCl, 20 KCl, 0.5 MgCl2, 10 HEPES, 10 Glucose, 0.1 CaCl2, and 100 D-mannitol
(pH 7.4). Voltage was then decreased to -100 mV for 100 ms and subsequently ramped to
+20 mV at a rate of 0.04 mV ms-1. Three trials were repeated consecutively (5 seconds
between each sweep) and the average current was recorded. After 5 minutes, cells were
mechanically stimulated by reducing bath osmolarity from 300 to 205 mosmol L-1 through
the removal of D-mannitol to induce swelling. Peak inward currents were then monitored
over a 16-minute window to observe changes in KIR activity. Traces were taken every
minute throughout the entire experiment. A variety of agents known to modulate
cytoskeletal and scaffolding proteins were added to the pipette solution including:
cytochalasin D (5 µM), latrunculin A (3 µM), caveolin-1 scaffolding domain peptide (cav1
SDP; amino acids 82–101 of cav1; 10 µM), and scrambled cav1 SDP (10 µM). Offset
potentials were minimized by placing a 1 M NaCl-agar salt bridge between the reference
electrode and the bath solution. All recordings were performed at room temperature (22
°C).
3.2.4. Immunofluorescence Staining
Protein expression of KIR2.1, KIR2.2, cav1, and syntrophin was assessed in isolated cerebral
smooth muscle cells. Cells were fixed in PBS containing 4% paraformaldehyde (15 min,
22 ºC) and washed 3 times with PBS prior to permeabilization with PBS containing 0.2%
Tween 20 (15 min, 22 ºC). A quench solution of PBS containing 0.2% Tween 20 and 3%
BSA was used to block cells for one hour (22 ºC). Primary antibodies (Appendix A Table
I) were diluted in quench solution and applied to cells for an overnight incubation (4 ºC).
The next day, cells were washed with PBS containing 0.2% Tween 20 and treated with
fluorophore-conjugated secondary antibodies (1 hour, 22 ºC). Either Alexa Fluor® 488
donkey anti-rabbit IgG (1:1000) or Alexa Fluor® 488 donkey anti-mouse IgG (1:1000)
secondary antibodies were applied based on primary antibody host species. After additional
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washes, cells were attached to slides with Prolong Diamond Antifade Mountant with DAPI
and sealed with nail polish. Control assays were conducted with the primary antibody
removed. Image capture of immunostaining was done using a Leica-TCS SP8 confocal
microscope with a 63× oil-immersion lens and processed using Leica LAS X software.
3.2.5. Proximity Ligation Assay
Proximity ligation assays were conducted with the Duolink in situ PLA detection kit with
isolated cerebral VSM cells. Cells were settled onto cover glass and fixed in PBS containing
4% paraformaldehyde (15 min, 22 ºC). After 3 washes with PBS, cells were blocked using
Duolink blocking solution in a heated humidity chamber (1 hour, 37 ºC). Primary
antibodies specific to KIR2.2 and either syntrophin or cav1 (Appendix A Table I) were
added to Duolink antibody diluent and applied to cells for an overnight incubation (4 ºC).
Controls were completed in parallel with either or both primary antibodies removed. The
next day, cells were washed 3 times with Duolink wash buffer and labelled with Duolink
PLA plus (rabbit) and minus (mouse) probes (1 hour, 37 ºC). PLA secondary probes are
labelled with oligonucleotides that hybridize only when tagged proteins are <40 nm from
one another. Following ligation (30 minutes, 37 ºC) and amplification of probe templates
(100 minutes, 37 ºC), far red fluorophore-tagged complementary oligonucleotides were
used to detect protein interactions. Nuclei were stained with Prolong Diamond Antifade
Mountant with DAPI and coverslips were sealed with nail polish. Images were captured
using a Leica-TCS SP8 confocal microscope with a 63× oil-immersion lens and processed
using Leica LAS X software.
3.2.6. Co-Immunoprecipitation
Cerebral arteries were dissected, cleaned, and placed in T-PER lysis buffer with an added
protease inhibitor cocktail (Sigma, P8340) containing (in mM): 104 AEBSF, 0.08
Aprotinin, 4 Bestatin, 1.4 E-64, 2 Leupeptin, and 1.5 Pepstatin A. Vessels were then
homogenized with a pestle grinder and centrifuged for 5 minutes at 10,000 g. The resulting
supernatant was collected, and protein content was determined with the Pierce BCA Protein
Assay kit. Co-immunoprecipitation of KIR2.2 was conducted same day using the
Dynabeads Protein A Immunoprecipitation kit. Before starting the assay, samples were precleared by incubating protein extracts with magnetic beads (35 min, 4 °C) to prevent non-
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specific binding. Magnetic beads were then coated with antibodies specific to KIR2.2 (5 µg,
Appendix A Table I) and cross-linked by an incubation in 5 mM BS3 (30 min, 22 ºC). Abcoated beads were then added to pre-cleared protein lysates and co-immunoprecipitation
was conducted as described in the Dynabeads Protein A standard protocol. Additional
controls were prepared by incubating protein lysate with rabbit IgG-coated (5 µg,
Appendix A Table I) and IgG-free beads. Supernatants collected before and after the first
wash step of the assay were reserved for further analysis to assess wash buffer stringency.
Precipitated protein complexes were further separated and detected by SDS-PAGE and
Western blot methods, respectively.
3.2.7. Western Blot
Following co-immunoprecipitation, bait-prey protein complexes were eluted from beads
using 6% SDS-PAGE buffer (10 min, 90 ºC), and loaded into 4% and 10% acrylamide
SDS-PAGE gels for separation (80 min, 100 V, 22 ºC). Proteins were then transferred from
the gel onto a nitrocellulose membrane overnight (25 V, 4 ºC). The next morning, the
membrane was blocked with a solution containing 5% non-fat dairy milk in 0.1% TBS-T
(1 hour, 22 ºC) prior to primary antibody incubation with either anti-KIR2.2 or antisyntrophin (Appendix A Table I) diluted in blocking solution (2 hours, 22 ºC). After three
washes in 0.1% TBS-T, either goat polyclonal anti-rabbit HRP or sheep anti-mouse HRP
secondary antibodies diluted in blocking solution (1:10,000) were applied to the membrane
(1 hour, 22 ºC). Following additional washes, Amersham ECL Prime Western Blotting
Reagent was applied to the membrane and images were captured on a Bio-Rad Gel Doc
system and processed using Image Lab 3.0 software.
3.2.8. Solutions & Chemicals
All chemicals and reagents were purchased from Sigma Aldrich unless otherwise stated.
Cytochalasin D and latrunculin A were obtained from Tocris Bioscience, papain from
Worthington. Antibodies for KIR2.1 and KIR2.2 were acquired from Alomone, cav1 (rabbit)
and syntrophin antibodies from Abcam. Alexa 488 Donkey anti-rabbit IgG, Alexa 488
Donkey anti-mouse IgG, goat anti-rabbit HRP secondary antibodies, anti-cav1 (mouse) and
Diamond Prolong Antifade Mountant were purchased from Thermofisher Scientific. Pierce
BCA Protein Assay and Dynabeads Protein A Co-Immunoprecipitation kits were also
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purchased from ThermoFisher Scientific. Amersham ECL Prime western blotting reagent
and Sheep Anti-Mouse HRP secondary antibodies were obtained from GE Healthcare. All
drug stock solutions were prepared in DMSO and the maximum final concentration of
DMSO exposed to cells never exceeded 0.01%.
3.2.9. Statistical Analysis
Data are expressed as means ± SEM, and n indicates the number of cells. No more than
two experiments were performed on cells collected from a single animal. Repeated
measures ANOVA, where appropriate, was used to assess the effects of treatment on
whole-cell KIR currents over time. Analysis was conducted using GraphPad Prism 8
(GraphPad Software; La Jolla, CA, USA). P < 0.05 was considered statistically significant.
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3.3 Results
3.3.1. Simulated Pressure Suppresses Cerebral KIR Channels
We began our assessment of KIR mechanosensitivity by first confirming its reactivity to
simulated pressure in isolated VSMCs. Whole-cell currents were measured under
conditions known to activate KIR channels (20 mM K+ bath) and subsequently swelled by
reducing bath osmolarity. Peak inward KIR currents (measured at -100 mV) were reduced
by 37% over a 16-minute recording period from the onset of cell swelling whereas cells
maintained under isosmotic conditions remained relatively stable (~7% decrease; Figure
3.1A-D). Suppression of KIR activity developed gradually, with maximal suppression
observed towards the end of the recording window. Furthermore, the stability of KIR
activity under isosmotic conditions verifies that the observed response to pressure was not
a result of channel rundown, a common limitation of the whole-cell patch clamp
configuration (Figure 3.1A&C). To address the molecular identity of the observed
currents, immunocytochemistry was conducted to screen for KIR subunits that are known
to form functional channels in cerebral arteries. Fluorescent labelling of isolated VSMCs
yielded a positive signal for both KIR2.1 and KIR2.2 subunits, with an expression pattern
that was concentrated towards the plasma membrane (Figure 3.1E). Staining was not
observed in control assays with primary antibodies removed.
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Figure 3.1: Simulated pressure suppresses KIR activity in isolated cells.
(A and B) Representative recordings of whole-cell KIR currents from rat cerebral arterial
smooth muscle cells in isosmotic (n = 6) and hyposmotic (n = 7) conditions. (C) Summary
data highlighting KIR suppression in hyposmotic bath over a 16-minute recording window,
RM-ANOVA was used to assess time-course changes in currents relative to time = 0. (D)
Percent difference of KIR current at 16 min vs 0 min. Data expressed as mean ± SEM, *
denotes significant difference at P < 0.05. (E) Immunostaining of isolated rat VSMCs with
antibodies specific to KIR2.1 or KIR2.2 (green). Nuclei are labelled with DAPI (blue) and
controls were conducted with primary antibodies removed from the assay. Each assay was
repeated with cells isolated from two animals.
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3.3.2. Disruption of the Actin Cytoskeleton Diminishes the KIR Pressure Response
As the cytoskeleton is often implicated in mechanical signal transduction pathways for its
force-transmitting properties, we next observed the impact of actin disruption on the KIR
pressure response. Patch clamp experiments previously outlined were repeated with either
cytochalasin D (5 µM) or latrunculin A (3 µM) introduced to the pipette solution. Both
reagents disturb actin but differ in their mechanisms; latrunculin A prevents the
polymerization of filamentous actin whereas cytochalasin D disrupts existing actin
structures. Despite varying mechanisms of action, both reagents similarly impaired the KIR
pressure response. Currents recorded at -100 mV in cytochalasin D and latrunculin A
treated cells decreased by 10% and 11%, respectively, while untreated cells decreased by
37% (Figure 3.2).
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Figure 3.2: An intact actin cytoskeleton is required for KIR pressure-sensing.
(A & B) Representative recordings of whole-cell KIR currents in swelled smooth muscle
cells exposed to latrunculin A (LA; 3 µM; n = 6) or cytochalasin D (CD; 5 µM; n = 7). (C)
Summary plot comparing changes of peak inward currents of untreated cells (n = 7) with
CD and LA treated groups over a 16-minute recording period in which cells were swelled
with hyposmotic bath solution. Time = 0 indicates isosmotic recording conditions. (D)
Percent difference of KIR current at 16 min vs 0 min. RM-ANOVA was used to assess timecourse changes in currents relative to time = 0. Data expressed as mean ± SEM, * denotes
significant difference at P < 0.05.
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3.3.3. Caveolin-1 Modulates KIR Activity During Hyposmotic Challenge
Many ion channels, including KIR2.x, are found within caveolae membrane structures
where they co-localize with other channels, scaffolding proteins, and signalling
components. We sought to determine the involvement of caveolae towards KIR activity
during mechanical stress. Cav1 was selected as it is the dominant smooth muscle isotype
expressed in VSM cells (Figure 3.3) (Drab et al., 2001). Application of cav1 SDP, a peptide
that interferes with the cav1 scaffolding domain (amino acids 82-101), prevented pressureinduced suppression of whole-cell KIR currents. Peak inward currents of cells treated with
cav1 SDP (10 µM) remained stable during cell-swelling but were reduced in cells treated
with a scrambled cav1 control peptide (27% decrease) (Figure 3.4A-D). Proximity ligation
assay confirmed the co-localization of KIR2.2 subunits with cav1 within 40 nm of one
another. Red fluorescent product was only observed in assays containing both KIR2.2 and
cav1 primary antibodies. Control assays with either or both primary antibodies removed
did not generate a signal (Figure 3.4E).
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Figure 3.3: KIR2.1, KIR2.1, caveolin-1, and syntrophin are expressed in arterial smooth
muscle. Immunofluorescence staining of smooth muscle cells isolated from rat cerebral
arteries with primary antibodies specific to KIR2.1, KIR2.2, syntrophin and caveolin-1
(green). Nuclei are labelled with DAPI (blue). Controls were conducted with primary
antibody removed. Each staining was repeated with cells isolated from two different
animals.
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Figure 3.4: KIR2.2 channels reside in caveolae and are regulated by caveolin-1.
(A & B) Representative recordings of whole-cell KIR currents in swelled smooth muscle
cells exposed to caveolin-1 scaffolding domain peptide (Cav1 SDP; 10 µM) and a
corresponding scrambled control peptide (10 µM). (C & D) Summary data highlighting
percent difference in peak inward current over a 16-minute recording period in peptide
treated (n = 5), scrambled peptide treated (n = 5), and untreated control (n = 7) cells
subjected to hyposmotic challenge. Time = 0 indicates isosmotic recording conditions.
RM-ANOVA was used to assess time-course changes in currents relative to time = 0. Data
expressed as mean ± SEM, * denotes significant difference at P <
0.05. (E) Proximity ligation assay indicates the presence of KIR2.2 channels in <40 nm
proximity to cav1 (red). Nuclei are stained with DAPI (blue). Control assays were
conducted with either or both primary antibodies removed. Images are representative of
replicate assays from three different animals.
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3.3.4. Syntrophin Co-Localizes with KIR2.2 in Isolated Smooth Muscle Cells
Proteomic studies have demonstrated that syntrophins directly bind KIR2.2 subunits in both
heart and brain tissue (Leonoudakis et al., 2004). Syntrophin is also known to bind the
actin-binding protein dystrophin and may facilitate a physical connection between the
channel and the cytoskeleton. Standard immunolabelling with a pan-specific syntrophin
antibody (recognizes α1, α2, and β1 isoforms of syntrophin) first confirmed its presence in
isolated VSMCs, where labelling was robust and concentrated at the membrane (Figure
3.3). We next examined the physical co-localization of KIR2.2 and syntrophin in cerebral
VSM with a proximity ligation assay. A red fluorescent product was observed in cells
probed with primary antibodies specific to KIR2.2 and syntrophin, indicating that the two
targets reside within 40 nm of one another (Figure 3.5). Signals were not observed in
control assays conducted with either or both primary antibodies removed.
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Figure 3.5: KIR2.2 and syntrophin co-localize in vascular smooth muscle.
Proximity ligation assay was performed on rat smooth muscle cells isolated from cerebral
arteries. Fluorescent products (red) indicate the presence of KIR2.2 channels in close
proximity (<40 nm) to syntrophin. Nuclei are stained with DAPI (blue). Control assays
were conducted with either or both primary antibodies removed. Images are representative
of replicate assays from three different animals.
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3.3.5. Exploring the KIR2.2-Syntrophin Relationship—Proposed Experiment
Building on our observations that syntrophin is both expressed in VSM and localized in
proximity to KIR2.2, our next logical step was to confirm a direct interaction between these
two proteins. We intended to conduct a co-immunoprecipitation (co-IP) assay to isolate
protein complexes bound to native KIR2.2 channels and probe them for syntrophin content.
Unfortunately, we were unable to resolve this experiment in time. Our approach and
progress to date are outlined below (Figure 3.6). The target protein KIR2.2 has not yet been
adequately captured onto ab-coated beads following lysate/bead incubations, as indicated
by the signal in the pre-wash column (#2) and lack of KIR2.2 band (expected at ~48 kDa)
in the KIR2.2 column (#4) (Figure 3.6B).We suspect that this is due to the low yield of
sample protein that can be sourced from rat cerebral arteries relative to what is typically
needed for co-immunoprecipitation assays. As KIR2.2 was detected in the 5% input lane,
we can determine that our lack of signal is an issue with protein capture and not antibody
specificity. Alternative vascular tissues, such as the aorta, may need to be substituted to
provide sufficient protein for the assay. This would, however, limit the translational value
of our findings towards the cerebral vasculature. Additional 55 kDa and heavier bands
observed in ab-coated bead columns (#4-5) are likely due to antibody co-elution with the
protein sample. This may be resolved by cross-linking the primary antibodies onto the
beads to avoid sample contamination during elution steps.
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Figure 3.6: Preliminary co-immunoprecipitation of KIR2.2 channels and syntrophin
(A) Outline of KIR2.2 co-immunoprecipitation procedure. Protein lysate is prepared from
homogenized rat cerebral arteries. Native KIR2.2 channels and bound complexes are then
collected from the lysate on anti-KIR2.2 coated magnetic beads, eluted, and separated via
SDS-PAGE. A western blot is then conducted to identify KIR2.2 and syntrophin. (B)
Current progress of KIR2.2 and syntrophin co-IP. KIR2.2 is detected in pre-wash but not abcoated bead lanes, signifying inadequate protein capture for pull-down. The prey protein
syntrophin was not screened for as the KIR2.2 target was not successfully captured. Bands
in lanes 4 and 5 are due to co-elution of primary antibodies with sample proteins from the
magnetic beads.
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3.4 Discussion
3.4.1. Research Summary
This study investigated structural proteins thought to mediate KIR pressure-sensitivity in
isolated cerebral myocytes. Simulated pressure was applied to isolated cells via hyposmotic
challenge, and KIR currents were recorded following a variety of treatments. KIR activity
was found to decrease during swelling in untreated cells but remained stable in cells
exposed to cytoskeleton disrupting agents latrunculin A and cytochalasin D. Pre-treatment
of cells with cav1 SDP also abolished pressure induced KIR suppression. Subsequent
experiments confirmed the expression and co-localization of KIR2.2 subunits with cav1 and
syntrophin scaffolding proteins in isolated cells. We propose that KIR mechanosensitivity
is reliant on cytoskeleton interactions facilitated by protein intermediates syntrophin and
cav1.
3.4.2. KIR Regulation by Pressure
Hemodynamic forces modulate the activity of ion channels present in VSM to induce VM
depolarization and Ca2+ influx (Welsh et al., 2000; Thorneloe & Nelson, 2005). The
recently observed pressure-sensitivity of KIR channels has implicated their involvement
alongside other mechanosensitive channels in facilitating myogenic depolarization. This
response has been documented in isolated cerebral arterial myocytes where hyposmotic
challenge, a stimulus that stretches the plasma membrane, suppressed KIR currents (Wu et
al., 2007; Sancho et al., 2019). Initial electrophysiology experiments confirmed previous
findings, observing that cell-swelling caused suppression of KIR activity over a period of
16 minutes (Figure 3.1). The stability of KIR activity in isosmotic conditions ruled out the
possibility of current rundown, a technical limitation of the whole-cell technique whereby
membrane rupture depletes intracellular solutes and impairs the activity of some channels
(Sarantopoulos et al., 2004). Further immunocytochemistry confirmed the presence of
KIR2.1 and KIR2.2 subunits—both of which are thought to form functional channels as
either as homo- or heteromultimers in cerebral VSM cells (Figure 3.1 and 3.3) (Bradley et
al., 1999; Schram et al., 2003; Sancho & Welsh, 2020).
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3.4.3. Modulation of KIR by the Actin Cytoskeleton
Two broad mechanisms exist to describe force modulation of mechanosensitive channels:
directly through membrane tension or indirectly through channel-tethered structural
proteins (Martinac, 2014). With respect to the latter mechanism, which is typically
observed in mammalian cells, the actin cytoskeleton is regularly implicated in indirect
mechanosensing processes for its inherent force-transmitting ability (Hayakawa et al.,
2008; Harris et al., 2018). As Figure 3.2 illustrates, KIR suppression by hyposmotic
challenge was largely prevented by treatment with cytochalasin D or latrunculin A. This is
supportive of the indirect model for KIR mechanosensitivity, demonstrating a functional
relationship between channels and the actin cytoskeleton. Important to note is the difference
in mechanism by which each agent disrupts the cytoskeleton: latrunculin A binds G-actin
to prevent its polymerization into F-actin, whereas cytochalasin D obstructs the barbed end
of F-actin to impede its interaction with other filaments and membrane structures (Coué et
al., 1987; Wakatsuki et al., 2001). As both drugs achieved a similar effect, it appears that
KIR channels interact with both existing actin filaments and those which are generated in
response to pressure. Several studies have described actin polymerization upon rising
pressure as a mechanism of myogenic tone development, and our findings indicate it may
also serve to modulate channel activity (Cipolla et al., 2002; Walsh & Cole, 2013). Despite
the broad nature of cytoskeleton disruption, KIR function appeared normal prior to swelling;
channels were readily activated by increasing extracellular [K+] (Appendix A
Supplementary Figure 1). These observations imply that the cytoskeleton is a crucial
element of KIR channel pressure-sensing and involves recruitment of both F and G-actin
pools.
3.4.4. Functional Organization of KIR Channels in Caveolae
Caveolae are small, curved structures within the plasma membrane that are found in
numerous cell types (Harvey & Calaghan, 2012; Je, Gallant, Leavis, & Morgan, 2004). In
VSM, their curvature is stabilized by the insertion of cav1 proteins into the plasma
membrane (Je et al., 2004). Functionally, caveolae form efficient mechanotransduction
complexes by concentrating receptors, ion channels, and other signalling components
within actin-coupled membrane microdomains (Echarri & Del Pozo, 2015). As VSM
KIR2.x channels reside in caveolae (Sancho et al., 2019), the present study assessed whether
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these structures were necessary for channel mechanosensation. In alignment with previous
work, cav1 was confirmed in VSM cells and in proximity with KIR2.2 (Figure 3.3 & 3.4).
Electrophysiology revealed that peptide blockade of the cav1 scaffolding domain (residues
82-101) prevented KIR suppression in isolated cells during hyposmotic challenge (Figure
3.4). These findings suggest that caveolae are active in mediating K IR pressure sensitivity,
particularly through cav1 interactions. The cav1 scaffolding domain has been deemed
essential for membrane attachment, therefore, blockade of this domain may have impacted
signal complex assembly by reducing membrane cav1 content (Schlegel, Schwab, Scherer,
& Lisanti, 1999). Caveolae are also known to associate with actin stress fibres to both
stabilize their membrane localization and receive mechanical inputs (Richter et al., 2008;
Sharma et al., 2010). Specifically, interactions between the cav1 scaffolding domain and
DAPC member β-dystroglycan are thought to mediate caveolae tethering to the
cytoskeleton (Sharma et al., 2010). Based on these observations, blockade of the cav1
scaffolding domain may have prevented caveolae-actin connections needed for KIR
pressure sensitivity. To summarize, these findings support the critical role that caveolae
structures and cav1 proteins play within KIR channel mechanotransduction processes.
Further work is needed to specify the precise mechanism by which caveolae and cav1
proteins confer mechanosensitivity to KIR channels in VSM.
3.4.5. KIR Interactions with Syntrophin
A number of protein binding partners have been identified for KIR2.x channels in several
tissues through proteomic analyses, including several members of the DAPC (Leonoudakis
et al., 2001, 2004; Willis et al., 2015). Syntrophins are among this group and are known to
bind KIR through a PDZ domain that recognizes a consensus motif (Ser-Glu-Ile) present at
the C-termini of KIR2.1 and KIR2.2 subunits. Immunocytochemistry first confirmed
syntrophin expression in VSM (Figure 3.3), while proximity ligation assay determined
their close proximity to KIR2.2 subunits (<40 nm) (Figure 3.5). Although these findings
confirm that syntrophins associate with KIR2.2 in vascular tissue, the physiological
significance of this interaction is yet to be determined. It is established that syntrophins,
through their interactions with dystrophin and the DAPC, can act as molecular adaptors to
recruit various signalling proteins and ion channels to the membrane. For example,
syntrophin has been deemed essential to the membrane localization and anchoring of
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aquaporin-4 channels in brain astrocytes (Amiry-Moghaddam et al., 2003). Furthermore,
Gavillet et al. reported reduced KIR2.1 protein but not mRNA in cardiomyocytes isolated
from dystrophin-deficient mdx mice (Gavillet et al., 2006). Alternatively, syntrophin has
also been implicated in mechanisms of ion channel mechanosensing for its ability to
facilitate connections between channels and actin-binding dystrophin (Leonoudakis et al.,
2004). In prior studies, syntrophins were found to link stretch-sensitive Na+ and Ca2+
channels with the DAPC and cytoskeleton via their PDZ motif—a feature thought to
mediate their mechanosensitivity (Ou et al., 2003; Vandebrouck et al., 2007). Given the
impact of cytoskeleton disruption on KIR mechanosensing, there is significant potential that
syntrophins couple KIR2.2 channels with actin in a similar manner. As the functional roles
of syntrophin towards ion channel activity and localization are diverse, further work is
needed to fully understand its relationship with KIR channels in arterial VSM.
3.4.6. Functional Implications and Conclusion
The myogenic response describes the constriction of resistance arteries in response to rising
intraluminal pressure. This process ensures constant blood flow to tissues where steady
perfusion is needed, such as the brain, and further protects downstream capillary networks
from damage (Cole & Welsh, 2011). Pressure initiates the myogenic response through
VSM depolarization, which has been historically attributed to the activation of stretchsensitive cation and Cl- channels (Nelson et al., 1997; Welsh et al., 2000). Our work
recognizes that KIR channels are also mechanosensitive in cerebral VSM, a trait which
implies their involvement in pressure-induced myogenic depolarization. Traditionally,
smooth muscle KIR channels are described as a resting K+ conductance that hyperpolarizes
VM to prevent contraction (Quayle et al., 1997). With this in mind, pressure-induced KIR
suppression should yield a depolarizing effect through the removal of its hyperpolarizing
outward current. This becomes apparent in whole vessel studies where Ba2+ blockade of
KIR channels elicits robust vasoconstriction, particularly at low intraluminal pressures
where the channel is most active (Wu et al., 2007; Sancho et al., 2019). Furthermore, the
suppression of KIR may also serve to maintain input resistance to offset the opening of other
depolarizing channels in VSM cells. Maintaining sufficient VSM input resistance enables
the conduction of electrical signals along the vessel wall as charge is retained rather than
dissipated (Diep et al., 2005). Considering this element of KIR regulation, we propose that
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the suppression of KIR channels coincides with the activation of depolarizing currents to
initiate the myogenic response.
To summarize, the present study examined mechanisms underlying KIR mechanosensitivity
in cerebral VSM cells. Simulated pressure using hyposmotic challenge suppressed KIR
currents in whole-cell recordings. Disruption of the actin cytoskeleton abolished this
response, as did cav1 interference. Scaffolding proteins cav1 and syntrophin were found in
proximity with KIR2.2 subunits in isolated cells, suggesting their participation in channel
mechanosensing. We propose that KIR mechanosensitivity is, in part, conferred by a
multiprotein complex of KIR2.2, syntrophin, actin, and caveolin-1 (Figure 3.7).
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Figure 3.7: Proposed mechanosignalling complex of smooth muscle KIR channels.
Syntrophin recognizes and binds the 3 amino acid C-terminal PDZ binding motif (S-E-I)
of KIR2.2 channels residing in caveolae formed by caveolin-1. Dystrophin binds both
syntrophin and filamentous actin, providing a physical link between the channel and
cytoskeleton for force transmission. These structural components form the signalling
complex required for KIR pressure sensitivity.
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Chapter 4:
Summary
4.1 Overview
The work presented in this thesis addressed both the molecular identity and mechanical
regulation of smooth muscle KIR channels in cerebral arteries. The first project entailed a
comprehensive examination of channel function in cerebral arteries using a smooth muscle
specific KIR2.1-/- model. In contrast with our initial hypothesis, SMC KIR2.1 knockout did
not alter KIR currents or vessel responses in cerebral arteries. These findings contradicted
those of previous studies and determined that KIR2.1 is not a critical component for VSMC
KIR function. Our interpretation suggests that the role of KIR2.1 is more subtle than
previously believed, and instead achieves its effects in combination with other KIR subunits
expressed in VSM. The second project explored signalling pathways underlying KIR
mechanosensitivity in isolated VSMCs. Guided by the results of the first study, experiments
were directed towards the KIR2.2 subunit. In line with our hypothesis, we reported
involvement of the actin cytoskeleton and cav1 scaffolding proteins towards the KIR
pressure response. The co-localization of syntrophin with KIR2.2 also supported the concept
that protein scaffolds facilitate actin-channel interactions. Taken together, the results from
both studies provide new perspectives on the composition of smooth muscle KIR channels,
their associated mechanotransduction complexes, and their role within the myogenic
response.

4.2 Functional Context of Findings
As demonstrated by the first project, cerebral vascular responses do not appear dependent
on smooth muscle KIR2.1 expression. KIR2.2 remains a likely candidate for the smooth
muscle KIR conductance as it has been previously observed in cerebral arteries and is
dominant to KIR2.1 at the transcript level (Vanlandewijck et al., 2018; He et al., 2018). At
first glance, the functional significance of this arrangement appears minimal due to the
similarities in subunit electrophysiological profiles. However, KIR2.1 and KIR2.2 are known
to differ in protein binding capability, which may in turn influence the formation of
signalling complexes. Leonoudakis et al. demonstrated that several members of the DAPC,
including syntrophin, associate more strongly with the C-terminus of KIR2.2 as opposed to
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KIR2.1 where interaction was weak. This disparity was attributed to differences in the PDZ
binding motifs and upstream amino acid sequences of these channels (Leonoudakis et al.,
2004). Given the importance of the DAPC towards cytoskeleton interactions and
mechanosensitive processes, we selected KIR2.2 as the subunit of interest in our second
project investigating KIR mechanosensitivity. This study identified several components
likely to participate in this process: actin, cav1, and syntrophin, of which the latter two were
found to co-localize with KIR2.2. Our perspective is that the KIR2.2 subunit is central to
channel mechanosensitivity and that this process mediates VSM depolarization to initiate
the myogenic response. By determining the molecular basis for this process, we are able to
better understand how these pathways may be altered in pathological states. Dysregulation
of VSM and subsequent disruption of myogenic tone development have been observed in
several diseases. Metabolic syndrome, a collection of closely related risk factors that
increase the likelihood of cardiovascular disease (Wassink et al., 2007), is a prime example
of this as vascular disorders such as hypertension, dyslipidemia, and atherosclerosis are
highly associated with this condition. Increased pressure-induced constriction has been
observed in cerebral arteries of obese Zucker rats, a common model for studying metabolic
syndrome (Brooks et al., 2015). Abnormal tone is also described in hypertension;
increasing intraluminal pressure causes excessive depolarization and vasoconstriction in
cerebral arteries of spontaneously hypertensive rats relative to healthy controls (Harder et
al., 1985; Jarajapu & Knot, 2005). Given our findings towards KIR2.2 channels as pressure
sensors, they should be examined in these disease contexts as their over/under expression
may translate to altered myogenic reactivity.
As we identified a likely role for syntrophin and the DAPC in KIR pressure sensing, diseases
that impact the expression of these proteins may also have consequences in the vasculature.
Duchenne muscular dystrophy is marked by the partial or complete loss of dystrophin in
muscle cells and is most recognized for its severe effects in skeletal muscle. As dystrophin
is also expressed in VSM, its absence may result in impaired VSM function and therefore
inadequate blood flow control. A retrospective analysis of scoliosis surgeries observed
greater blood loss DMD patients compared to idiopathic cases, and considered VSM
dysfunction as an underlying cause (Noordeen et al., 1999). Another study determined that
abnormal surgical bleeding in DMD patients occurs without platelet abnormalities, further
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suggestive of altered vessel reactivity (Turturro et al., 2005). KIR channels may play a role
in this pathology given their contribution to the myogenic response and newly observed
interactions with DAPC proteins.

4.3 Limitations
Blood pressure measurements recorded during live animal imaging experiments in the first
project were limited by equipment incompatibilities with the MRI scanner. Briefly, an
external tail-cuff system was used in place of a more sensitive fluid filled intra-arterial
catheter because it could be employed from a greater distance away from the scanner’s
magnetic field. Tail-cuff measurements are less reflective of central arterial pressure as the
tail artery is more sensitive to temperature and vasoactive substances, which may have
impacted pressure recordings (Mittnacht et al., 2011).
Throughout the second project, mechanical stimulation of isolated cells was achieved
through hyposmotic challenge—a process where the surrounding bath osmolarity is
reduced to initiate cell-swelling and membrane stretch. Although it is well-established that
this technique modulates mechanosensitive ion channels, it is limited by its relatively slow
onset of stimulation. According to established criteria, this makes it difficult to distinguish
whether KIR channels are directly activated by membrane tension (<5 ms response) or
indirectly through the recruitment of additional signalling molecules (>5 ms response)
(Christensen & Corey, 2007). Another area to consider is the broad nature of cytoskeleton
disruption across the cell. The actin cytoskeleton is known to regulate a variety of cellular
processes and can modulate the activity of other channels expressed in VSM. For example,
cytochalasin D has been demonstrated to interfere with VGCC Ca2+ influx in cerebral
arteries (Gokina & Osol, 2002). To account for this, bath and pipette solutions used in patch
clamp experiments were designed to record KIR currents in isolation from other native
conductances. Still, the potential influence of cytoskeleton disruption on other currents and
cellular processes cannot be overlooked.

4.4 Future Directions
The weak phenotype observed following genetic knockout of KIR2.1 in the first study
prompts the consideration of other KIR2.x subunits when examining KIR attributed vascular
responses. As recent RNA sequencing studies indicate higher transcript expression of
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KIR2.2 relative to KIR2.1, studies seeking to perturb smooth muscle inward K+ currents may
achieve a greater effect by targeting KIR2.2 (Vanlandewijck et al., 2018; He et al., 2018).
As observed in the second project, KIR2.2 and syntrophin reside in close proximity to one
another in VSM cells. Though co-localization is supportive of their interaction, it is unable
to determine whether syntrophin directly binds the channel. Co-immunoprecipitation of
KIR2.2 subunits from cerebral arterial myocytes would allow for the capture of bound
protein complexes, which may in turn be screened for syntrophin. This would resolve
whether direct KIR-syntrophin interactions previously observed in brain and cardiac tissue
are also present in native VSM cells (Leonoudakis et al., 2004). As discussed, syntrophin
is of interest for its ability to couple channels to the cytoskeleton. As such, it would also be
beneficial to assess the functional impact of syntrophin disruption on whole-cell KIR
currents during osmotic challenge. Peptides can be directed towards either the PDZ domain
of syntrophin or the PDZ binding motif of KIR2.2 and introduced to the pipette solution for
further patch clamp recordings. This technique was described by Ou et al., where
syntrophin blockade prevented the activation of mechanosensitive Na+ channels in jejunal
smooth muscle (Ou et al., 2003). Finally, future incorporation of intact vessel experiments
would allow for translation of observations beyond the isolated cell level.

4.5 Concluding Remarks
The work presented in this thesis explored how smooth muscle KIR channels contribute to
myogenic tone development in cerebral arteries. KIR2.1 was found to play a limited role
within cerebral VSM, with present data supportive of KIR2.2 as the dominant subtype.
Further examination of channel mechanosensitivity identified functional interactions with
actin and caveolin-1, while syntrophin remains a likely participant in complex formation
and cytoskeleton tethering. We propose that KIR pressure sensitivity allows channels to
contribute to the initiation of the myogenic response within cerebral arteries.
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Appendices:
Appendix A – Supplementary Materials:
Supplementary Table I:
Antibody

Application

[Ab]

Supplier/

Host

Cat #
KIR2.1

ICC

1:200

Alomone,

Rabbit

APC-026
KIR2.2

Syntrophin
Caveolin-1

ICC, PLA

1:200

Alomone,

WB

1:400

APC-042

Co-IP

x

ICC, PLA

1:200

Abcam.

WB

1:1000

ab11425

ICC

1:200

Abcam,

Rabbit

Mouse
Rabbit

ab2910
Caveolin-1

PLA

1:200

ThermoFisher,
MA3-600

Mouse

Alexa Fluor® 488
anti-Rabbit IgG

ICC

1:1000

Thermofisher,
A21206

Donkey

Alexa Fluor® 488
anti-Mouse IgG

ICC

1:1000

Thermofisher,
A21202

Donkey

anti-Mouse IgG
HRP

WB

1:10,000

GE Healthcare
UK, NXA931V

Sheep

anti-Rabbit IgG
HRP

WB

1:10,000

ThermoFisher.
65-6120

Goat

Normal Rabbit IgG

Co-IP

x

Sigma-Aldrich,
12-370

Rabbit

Legend: ICC – Immunocytochemistry, PLA – Proximity Ligation Assay, WB – Western
Blot, Co-IP – Co-immunoprecipitation.
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Supplementary Figure I: Actin disruption did not affect KIR activation by
extracellular K+. Summary data highlighting KIR activation by extracellular K+ following
actin disruption in isolated cerebral VSM cells. Data representative of peak inward KIR
currents from untreated cells (n = 6), cells treated with latrunculin A (3 µM; n = 6) or
cytochalasin D (5 µM; n = 7). Paired t-test assessed differences between currents recorded
before and after [K+]o elevation from 5 mM to 20 mM. Data expressed as mean ± SEM, *
denotes significant difference at P < 0.05.
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Appendix B – Animal Use Protocol:
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